- Brendan McDermid/Reuters
Bristol-Myers shares gained as much as 5% in late trading on Tuesday after the news crossed.
Bristol-Myers announced earlier Tuesday an expanded share-buyback program, and named three new board members, following pressure from activist investor Jana Partners. The companies had been in talks since Jana Partners became a shareholder in the fourth quarter, Bristol-Myers said.
Icahn sees value in the company’s pipeline of drugs which currently includes treatments for heart diseases and cancer, the report said.
- Markets Insider